| 标题 |
Research Letter Refining HEPAmet for treatment eligibility in MASLD: External Validation and Guardrail to Exclude Cirrhosis, Limit Early Disease |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)